Steris Plc Stock Earnings Per Share
STE Stock | USD 230.00 0.05 0.02% |
STERIS Plc fundamentals help investors to digest information that contributes to STERIS Plc's financial success or failures. It also enables traders to predict the movement of STERIS Stock. The fundamental analysis module provides a way to measure STERIS Plc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to STERIS Plc stock.
STERIS | Earnings Per Share |
STERIS Earnings Per Share Analysis
STERIS Plc's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
More About Earnings Per Share | All Equity Analysis
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 4.6B | 5.0B | 5.7B | 6.0B | Depreciation And Amortization | 553.1M | 982.1M | 1.1B | 1.2B |
Earnings per Share | = | EarningsAverage Shares |
Current STERIS Plc Earnings Per Share | 5.68 X |
Most of STERIS Plc's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, STERIS Plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
STERIS Earnings Per Share Driver Correlations
Understanding the fundamental principles of building solid financial models for STERIS Plc is extremely important. It helps to project a fair market value of STERIS Stock properly, considering its historical fundamentals such as Earnings Per Share. Since STERIS Plc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of STERIS Plc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of STERIS Plc's interrelated accounts and indicators.
Click cells to compare fundamentals
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
Competition |
STERIS Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
According to the company disclosure, STERIS Plc has an Earnings Per Share of 5.68 times. This is 32.14% lower than that of the Health Care Equipment & Supplies sector and notably higher than that of the Health Care industry. The earnings per share for all United States stocks is 82.05% lower than that of the firm.
STERIS Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses STERIS Plc's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of STERIS Plc could also be used in its relative valuation, which is a method of valuing STERIS Plc by comparing valuation metrics of similar companies.STERIS Plc is currently under evaluation in earnings per share category among related companies.
STERIS Fundamentals
Return On Equity | 0.0911 | ||||
Return On Asset | 0.0477 | ||||
Profit Margin | 0.10 % | ||||
Operating Margin | 0.16 % | ||||
Current Valuation | 26.05 B | ||||
Shares Outstanding | 98.81 M | ||||
Shares Owned By Insiders | 0.27 % | ||||
Shares Owned By Institutions | 97.96 % | ||||
Number Of Shares Shorted | 2.46 M | ||||
Price To Earning | 36.93 X | ||||
Price To Book | 3.54 X | ||||
Price To Sales | 4.20 X | ||||
Revenue | 4.96 B | ||||
Gross Profit | 2.16 B | ||||
EBITDA | 1.25 B | ||||
Net Income | 105.81 M | ||||
Cash And Equivalents | 208.36 M | ||||
Cash Per Share | 3.16 X | ||||
Total Debt | 3.02 B | ||||
Debt To Equity | 0.49 % | ||||
Current Ratio | 2.03 X | ||||
Book Value Per Share | 64.93 X | ||||
Cash Flow From Operations | 756.95 M | ||||
Short Ratio | 5.11 X | ||||
Earnings Per Share | 5.68 X | ||||
Price To Earnings To Growth | 6.88 X | ||||
Target Price | 240.43 | ||||
Number Of Employees | 17 K | ||||
Beta | 0.8 | ||||
Market Capitalization | 22.73 B | ||||
Total Asset | 10.82 B | ||||
Retained Earnings | 1.91 B | ||||
Working Capital | 1.15 B | ||||
Current Asset | 972.52 M | ||||
Current Liabilities | 400.61 M | ||||
Z Score | 5.73 | ||||
Annual Yield | 0.01 % | ||||
Five Year Return | 0.96 % | ||||
Net Asset | 10.82 B | ||||
Last Dividend Paid | 1.98 |
About STERIS Plc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze STERIS Plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of STERIS Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of STERIS Plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.STERIS plc provides infection prevention and other procedural products and services worldwide. The company was founded in 1985 and is based in Dublin, Ireland. Steris Corp operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 16000 people.
Currently Active Assets on Macroaxis
ABBV | AbbVie Inc | |
HBI | Hanesbrands | |
MIDU | Direxion Daily Mid | |
V | Visa Class A | |
ORCL | Oracle |
Check out STERIS Plc Piotroski F Score and STERIS Plc Altman Z Score analysis. For information on how to trade STERIS Stock refer to our How to Trade STERIS Stock guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for STERIS Stock analysis
When running STERIS Plc's price analysis, check to measure STERIS Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STERIS Plc is operating at the current time. Most of STERIS Plc's value examination focuses on studying past and present price action to predict the probability of STERIS Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move STERIS Plc's price. Additionally, you may evaluate how the addition of STERIS Plc to your portfolios can decrease your overall portfolio volatility.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is STERIS Plc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STERIS Plc. If investors know STERIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STERIS Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.145 | Dividend Share 1.98 | Earnings Share 5.68 | Revenue Per Share 54.709 | Quarterly Revenue Growth 0.148 |
The market value of STERIS Plc is measured differently than its book value, which is the value of STERIS that is recorded on the company's balance sheet. Investors also form their own opinion of STERIS Plc's value that differs from its market value or its book value, called intrinsic value, which is STERIS Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STERIS Plc's market value can be influenced by many factors that don't directly affect STERIS Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STERIS Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if STERIS Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STERIS Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.